Preventing Strokes and Heart Attacks Doesn't Have to Come with the Risk of Life-threatening Bleeding
Preventing Strokes and Heart Attacks Doesn't Have to Come with the Risk of Life-threatening Bleeding

FREMONT, CA, Dec 14, 2022 – (ACN Newswire via SEAPRWire.com) – Verseon is delighted to announce that the European Journal of Medicinal Chemistry has published a paper (www.sciencedirect.com/science/article/abs/pii/S0223523422007577) describing the company’s groundbreaking research that led to promising novel drug candidates for cardiovascular disease. Cardiovascular disease is the leading cause of death and disability in the... » read more

AIM Vaccine Announces Global Offering Results, Offer Price of HK$16.16 per H Share

HONG KONG, Oct 5, 2022 – (ACN Newswire via SEAPRWire.com) – AIM Vaccine Co., Ltd. (“AIM Vaccine” or the “Company”, together with its subsidiaries, the “Group”, stock code: 06660.HK), the second largest vaccine company in China in terms of 2021 approved lot release volume (excluding COVID-19 vaccines), today announced the allotment results of its Global... » read more

AIM Vaccine Announces Proposed Listing on the Main Board of SEHK
AIM Vaccine Announces Proposed Listing on the Main Board of SEHK

HONG KONG, Sep 23, 2022 – (ACN Newswire via SEAPRWire.com) – AIM Vaccine Co., Ltd. (“AIM Vaccine” or the “Company”, together with its subsidiaries, the “Group”, stock code: 06660.HK), the second largest vaccine company in China in terms of 2021 approved lot release volume (excluding COVID-19 vaccines), announced the proposed listing of its H shares... » read more

Lepu Biopharma Co., Ltd. Successfully Listed on the Main Board of HKEX
Lepu Biopharma Co., Ltd. Successfully Listed on the Main Board of HKEX

HONG KONG, Feb 23, 2022 – (ACN Newswire via SEAPRWire.com) – The biopharmaceutical company focusing on oncology therapeutics – Lepu Biopharma Co., Ltd. (“Lepu Biopharma” or the “Company”, stock code: 2157.HK), has successfully listed and commenced dealings on the Main Board of the Stock Exchange of Hong Kong Limited (“Hong Kong Stock Exchange”) today, under... » read more

Sirnaomics Ltd. Announces Proposed Listing on the Main Board of SEHK

HONG KONG, Dec 19, 2021 – (ACN Newswire via SEAPRWire.com) – Sirnaomics Ltd. (“Sirnaomics” or “Company”, stock code: 2257.HK), the RNA therapeutics biopharmaceutical company withs strong presence in both China and the U.S., today announces the proposed listing of its shares on the Main Board of The Stock Exchange of Hong Kong Limited (“SEHK”). Sirnaomics... » read more